We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$7.15B
AUM Growth
+$778M
Cap. Flow
+$799M
Cap. Flow %
11.18%
Top 10 Hldgs %
9.56%
Holding
5,720
New
998
Increased
1,852
Reduced
1,702
Closed
889

Sector Composition

Rank Sector Weight
1 Healthcare 3.37%
2 Technology 1.88%
3 Consumer Discretionary 1.68%
4 Energy 1.47%
5 Financials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCMP
3926
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$17K ﹤0.01%
+1,027
New +$17.8K
TEAR
3927
PUT
DELISTED
TearLab Corporation
TEAR
$17K ﹤0.01%
850
-7,990
-90% -$187K
FUR
3928
PUT
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
$17K ﹤0.01%
1,100
-27,100
-96% -$437K
UNIS
3929
PUT
DELISTED
Unilife Corporation
UNIS
$17K ﹤0.01%
800
+740
+1,233% +$22.4K
REDF
3930
CALL
DELISTED
REDIFF.COM INDIA LTD ADS
REDF
$17K ﹤0.01%
9,600
+3,400
+55% +$6.37K
CTCT
3931
CALL
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$17K ﹤0.01%
600
-3,200
-84% -$102K
PDLI
3932
PUT
DELISTED
PDL BioPharma, Inc.
PDLI
$17K ﹤0.01%
2,600
-8,800
-77% -$58.9K
UN
3933
CALL
DELISTED
Unilever NV New York Registry Shares
UN
$17K ﹤0.01%
400
+300
+300% +$12.9K
ALDW
3934
DELISTED
Alon USA Partners LP
ALDW
$17K ﹤0.01%
820
+500
+156% +$10.1K
ABEO icon
3935
CALL
Abeona Therapeutics
ABEO
$413M
$16K ﹤0.01%
+124
New +$18.6K
BCLI
3936
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$16K ﹤0.01%
+292
New +$17.4K
CDW icon
3937
CDW
CDW
$17B
$16K ﹤0.01%
+458
New +$17.1K
HBAN icon
3938
Huntington Bancshares
HBAN
$35.5B
$16K ﹤0.01%
1,452
KEYS icon
3939
Keysight
KEYS
$58.3B
$16K ﹤0.01%
+500
New +$17.1K
LXRX icon
3940
PUT
Lexicon Pharmaceuticals
LXRX
$1.1B
$16K ﹤0.01%
+2,000
New +$14.7K
MARA icon
3941
Marathon Digital Holdings
MARA
$3.85B
$16K ﹤0.01%
+344
New +$27.1K
NEON icon
3942
PUT
Neonode
NEON
$16.2M
$16K ﹤0.01%
530
+430
+430% +$16.3K
PBA icon
3943
CALL
Pembina Pipeline
PBA
$27.6B
$16K ﹤0.01%
500
+100
+25% +$3.35K
PBA icon
3944
PUT
Pembina Pipeline
PBA
$27.6B
$16K ﹤0.01%
500
TBPH icon
3945
PUT
Theravance Biopharma
TBPH
$877M
$16K ﹤0.01%
+1,200
New +$18.6K
TDS icon
3946
Telephone and Data Systems
TDS
$3.75B
$16K ﹤0.01%
+528
New +$15.2K
TGNA
3947
CALL
DELISTED
TEGNA Inc
TGNA
$16K ﹤0.01%
781
-748
-49% -$14.1K
VJET
3948
PUT
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$16K ﹤0.01%
460
-8,000
-95% -$323K
PDCE
3949
CALL
DELISTED
PDC Energy, Inc.
PDCE
$16K ﹤0.01%
300
-4,000
-93% -$226K
RBCN
3950
DELISTED
Rubicon Technology, Inc.
RBCN
$16K ﹤0.01%
642
-27
-4% -$881

Similar funds

Group One Trading's Q2 2015 Portfolio in Review

As of Q2 2015, Group One Trading held 5,720 positions worth $7.15B, up 12% from $6.37B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Group One Trading deployed $799M of net new capital in Q2 2015, opening 998 new positions and adding to 1,852 existing holdings. Its largest new stake was Viatris: 122,934 shares worth $8.34M.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, up from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Allergan plc, an estimated $21.2M trimmed.

  • Group One Trading's largest Q2 2015 buy was Viatris: 122,934 shares worth $8.34M.
  • Group One Trading added most to Williams Companies in Q2 2015, an estimated $22.3M increase.
  • Group One Trading's biggest Q2 2015 reduction was Allergan plc, cutting an estimated $21.2M.
  • Group One Trading fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $89.2M.
  • Group One Trading's ten largest holdings make up 9.6% of its $7.15B portfolio in Q2 2015.
  • Group One Trading opened 998 new positions and closed 889 in Q2 2015.
  • Group One Trading's portfolio value rose 12% quarter-over-quarter to $7.15B.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.